The remaining genes, i.e. BLNK [55], MYO7A [56], VNN2 [57], OTOA [58], SLC8A1 [59] and DTX4 [60], might also serve as potential biomarkers for AML. The gene discussed is OTOA; the disease is acute myeloid leukemia.